It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The self-assembly of noble metal nanoparticles into periodic structures has been a theme of great interest for surface-enhanced Raman scattering (SERS) and use in functional devices. However, small nanoparticle self-assembly faces numerous challenges in tunability, referring to controlling their structural properties like structure, gaps, and arrangement. These issues highlight the need for further research and development to enhance the tunability and stability of self-assembled small nanoparticles. Here, we report a general centimeter-scale superlattice assembly strategy for noble metal nanoparticles less than 15 nm in size. Not only is this monolayer superlattice assembly generally applicable to different kinds and sizes of noble metal nanoparticles, but also, the crystal plane spacing can also be quickly and conveniently controlled by changing the ethanol concentration. SERS results reveal that optimized superlattice membranes of noble metal nanoparticles possess high detection sensitivity and ordered hot spots. Therefore, our strategy offers prospects for high-performance SERS substrates based on small noble metal nanoparticle superlattices.
Self-assembly of small nanoparticles is difficult to control and the resultant structures have weak stability. Here, a general centimeter-scale superlattice assembly strategy for noble metal nanoparticles of less than 15 nm is used to yield stable hexagonal close-packed monolayers.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 University of Science and Technology of China, Hefei, China (GRID:grid.59053.3a) (ISNI:0000 0001 2167 9639); Chinese Academy of Sciences, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Hefei, China (GRID:grid.9227.e) (ISNI:0000000119573309)
2 Chinese Academy of Sciences, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Hefei, China (GRID:grid.9227.e) (ISNI:0000000119573309); Chinese Academy of Sciences, Department of Pharmacy, Hefei Cancer Hospital, Hefei, China (GRID:grid.9227.e) (ISNI:0000 0001 1957 3309)
3 Chinese Academy of Sciences, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Hefei, China (GRID:grid.9227.e) (ISNI:0000000119573309); Anhui Cas-art Technology Co. Ltd, Heifei, China (GRID:grid.9227.e)
4 University of Science and Technology of China, Hefei, China (GRID:grid.59053.3a) (ISNI:0000 0001 2167 9639); Chinese Academy of Sciences, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Hefei, China (GRID:grid.9227.e) (ISNI:0000000119573309); Chinese Academy of Sciences, Department of Pharmacy, Hefei Cancer Hospital, Hefei, China (GRID:grid.9227.e) (ISNI:0000 0001 1957 3309)